Literature DB >> 2224779

Genetic diagnosis of Lynch syndrome II in an extended colorectal cancer-prone family.

H T Lynch1, E K Bronson, P C Strayhorn, T C Smyrk, J F Lynch, E J Ploetner.   

Abstract

Knowledge of colon cancer genetics, with particular attention to precision in hereditary cancer syndrome diagnosis, can often enable highly targeted surveillance and management strategies for patients at high genetic risk. Unfortunately, the patient's family history of cancer is often given minimal attention, and knowledge of hereditary cancer syndromes is frequently limited. Indeed, many physicians still consider familial adenomatous polyposis (FAP) as the only genetic risk factor for colorectal cancer. This concern with FAP was noted in a colorectal cancer-prone kindred which for decades had been thought to manifest that syndrome. However, after meticulous genetic, medical, and pathologic studies, the cardinal phenotypic characteristics of Lynch syndrome II were observed. The potential for cancer control in current and future generations of families like this one clearly mandates the need for computerized registries which could transmit current information about hereditary colon cancer syndrome diagnosis, surveillance, and management.

Entities:  

Mesh:

Year:  1990        PMID: 2224779     DOI: 10.1002/1097-0142(19901115)66:10<2233::aid-cncr2820661033>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

Review 1.  Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.

Authors:  Gregory Kouraklis; Evangelos P Misiakos
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

2.  Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage.

Authors:  M Nyström-Lahti; R Parsons; P Sistonen; L Pylkkänen; L A Aaltonen; F S Leach; S R Hamilton; P Watson; E Bronson; R Fusaro
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.